The optimal oral biopsy site for diagnosis of mucous membrane pemphigoid and pemphigus vulgaris

• Published in: British journal of dermatology (1951) Vol. 182; no. 3; pp. 747 - 753
• Main Authors: Carey, B., Joshi, S., Abdelghani, A., Mee, J., Andiappan, M., Setterfield, J.
• Format: Journal Article
• Language: English
• Published: England Oxford University Press 01-03-2020
• Subjects: Alveoli; Autoimmune diseases; Biopsy; Buccal mucosa; Bullous pemphigoid; Diagnosis; Histology; Humans; Immunofluorescence; Medical diagnosis; Pemphigoid, Benign Mucous Membrane - diagnosis; Pemphigoid, Bullous; Pemphigus; Pemphigus - diagnosis; Retrospective Studies; Serology; Skin diseases
• ISSN: 0007-0963; 1365-2133
• DOI: 10.1111/bjd.18032

Summary
Background
Accepted ‘standard practice’ for the diagnosis of immunobullous disease is a perilesional sample for direct immunofluorescence (DIF).
Objectives
To compare diagnostic outcomes of a normal buccal punch biopsy (NBPB) with a perilesional biopsy (PLB) for mucous membrane pemphigoid (MMP) and pemphigus vulgaris (PV).
Methods
A retrospective analysis of 251 DIF‐positive patients with MMP and 77 DIF‐positive patients with PV was undertaken. Parameters analysed included the intraoral sites of involvement and histopathological, DIF and indirect immunofluorescence (IIF) findings.
Results
For MMP, PLB was positive in 134 of 143 (93·7%) samples, compared with 129 of 144 (89·6%) by NBPB. The diagnostic sensitivities for PLB (81%, 39 of 48) and NBPB (77%, 37 of 48) among 48 patients who underwent both techniques were not significantly different (P = 0·62). In gingival‐only MMP, PLB was positive in 63 of 69 (91%) and NBPB was positive in 63 of 75 (84%). For multisite MMP, PLB was positive in 71 of 74 (96%) and NBPB was positive in 66 of 69 (96%). In gingival‐only MMP, biopsies from reflected alveolar mucosa in 17 consecutive patients were positive in 17 of 17 cases (100%). For PV, PLB was positive in 42 of 43 (98%), compared with 42 of 42 (100%) by NBPB. Histopathology was diagnostic in 93 of 134 (69·4%) cases of MMP and 38 of 41 (93%) cases of PV. IIF was positive in 126 of 197 (64·0%) MMP and 68 of 74 (92%) PV patient sera.
Conclusions
In the largest series of combined oral DIF results in patients with MMP and PV, we have shown that NBPB is equivalent to PLB for the diagnosis of PV and multisite MMP, and is more sensitive than both histology and IIF.
What's already known about this topic?
The variation in sensitivity of oral biopsy sites for direct immunofluorescence (DIF) in the diagnosis of oral MMP and PV has not been studied in detail in large series of patients.
Biopsy can be challenging due to difficult access and fragility of the oral mucosa. The diagnostic biopsy technique is therefore critical.
What does this study add?
We have shown that a normal buccal punch biopsy (NBPB) from uninvolved oral mucosa is as sensitive as a perilesional biopsy (PLB) for diagnosis of oral PV, and superior to serology and histology.
For multisite MMP, NBPB is equivalent to PLB and is more sensitive than serology and histology.
The oral punch biopsy technique on uninvolved buccal mucosa tissue is a simple and safe practical method for diagnosing oral PV and MMP.
Linked Comment: Maglie and Hertl. Br J Dermatol 2020; 182:539–540.
Plain language summary available online